Production (Stage)
Oragenics, Inc.
OGEN
$4.28
$0.7521.25%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -48.52% | -84.92% | 14.24% | -54.81% | -60.34% |
| Gross Profit | 48.52% | 84.92% | -15.37% | 54.51% | 59.93% |
| SG&A Expenses | -6.23% | -3.65% | 16.93% | 25.40% | 43.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.64% | -73.78% | 15.96% | -26.15% | -15.80% |
| Operating Income | 17.64% | 73.78% | -16.37% | 25.84% | 15.31% |
| Income Before Tax | 9.54% | 73.73% | -22.36% | 24.44% | 13.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 9.54% | 73.73% | -22.36% | 24.44% | 13.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.54% | 73.73% | -22.36% | 24.44% | 13.85% |
| EBIT | 17.64% | 73.78% | -16.37% | 25.84% | 15.31% |
| EBITDA | -- | 73.83% | -16.30% | 25.78% | 15.21% |
| EPS Basic | 82.64% | 94.29% | 55.84% | 66.22% | 50.28% |
| Normalized Basic EPS | 82.63% | 94.29% | 55.84% | 66.22% | 50.29% |
| EPS Diluted | 82.64% | 94.29% | 55.84% | 66.22% | 50.28% |
| Normalized Diluted EPS | 82.63% | 94.29% | 55.84% | 66.22% | 50.29% |
| Average Basic Shares Outstanding | 421.04% | 360.12% | 177.07% | 123.68% | 73.28% |
| Average Diluted Shares Outstanding | 421.04% | 360.12% | 177.07% | 123.68% | 73.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |